• Molecular NameSulfacytine
  • Synonym1-ethyl N4-sulfanilylcytosin; 1-ethyl-N-sulfanilylcytosine; N-sulfanilyl-l-ethylcytosine; Sulfacitina [inn-spanish]; Sulfacitinum [inn-latin]
  • Weight294.335
  • Drugbank_IDDB01298
  • ACS_NO17784-12-2
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-0.35
  • pkaN/A
  • LogD (pH=7, predicted)-0.72
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.22
  • LogSw (predicted, AB/LogsW2.0)1.04
  • Sw (mg/ml) (predicted, ACD/Labs)8.14
  • No.of HBond Donors3
  • No.of HBond Acceptors7
  • No.of Rotatable Bonds4
  • TPSA113.24
  • StatusFDA approved; US withdrawn
  • AdministrationN/A
  • PharmacologyN/A
  • Absorption_valueN/A
  • Absorption (description)Well absorbed following oral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A